Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients
- 31 May 2008
- journal article
- research article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 395 (1-2), 106-110
- https://doi.org/10.1016/j.cca.2008.05.018
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: Homocysteine-Lowering Is Not a Primary Target for Cardiovascular Disease Prevention in Chronic Kidney Disease PatientsSeminars in Dialysis, 2007
- Hyperhomocysteinemia, Malnutrition, and Inflammation in ESRD PatientsSeminars in Nephrology, 2006
- Hyperhomocysteinemia and response of methionine cycle intermediates to vitamin treatment in renal patientscclm, 2005
- Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapyAmerican Journal of Kidney Diseases, 2004
- S-adenosylhomocysteine is a more sensitive indicator of renal insufficiency than homocysteineNutrition Research, 2004
- Homocysteine and Renal DiseaseSeminars in Thrombosis and Hemostasis, 2000
- Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patientsKidney International, 2000
- Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitusKidney International, 1999
- Evidence for disturbed S-adenosylmethionine: S-adenosylhomocysteine ratio in patients with end-stage renal failure: a cause for disturbed methylation reactions?Nephrology Dialysis Transplantation, 1998
- Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patientsKidney International, 1996